|
× |
 |
The Effect of Staff Training on Agitation and Use of Restraint in Nursing Home Residents With Dementia: A Single-Blind, Randomized Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prophylactic Treatment With Escitalopram of Pegylated Interferon Alfa-2a-Induced Depression in Hepatitis C: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Relationship of Personality Disorders to Treatment Outcome in Depressed Outpatients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Divalproex Sodium Treatment of Women With Borderline Personality Disorder and Bipolar II Disorder: A Double-Blind Placebo-Controlled Pilot Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
No MMSE for You! A Case of an "Uncooperative" Patient With Early-Onset Dementia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders PDF |
$40.00 |
|
$40.00 |
|
× |
|
Quality of Life in Schizophrenia: The Impact of Psychopathology, Attitude Toward Medication, and Side Effects PDF |
$40.00 |
|
$40.00 |
|
× |
|
Factors Associated With Oral Anticoagulant Use in Patients With Atrial Fibrillation and Mental Disorders PDF |
$40.00 |
|
$40.00 |
|
× |
|
To Be Continued? Long-Term Treatment Effects of Antidepressant Drug Classes and Individual Antidepressants on the Risk of Developing Dementia: A German Case-Control Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Reboxetine, a Unique Selective NRI, Prevents Relapse and Recurrence in Long-Term Treatment of Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Association Between Enhanced Soluble CD40 Ligand and Proinflammatory and Prothrombotic States in Major Depressive Disorder: Pilot Observations on the Effects of Selective Serotonin Reuptake Inhibitor Therapy PDF |
$40.00 |
|
$40.00 |
|
× |
|
Mental Health From the Perspective of Primary Care Residents: A Pilot Survey PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Effects of Mirtazapine on Plasma Lipid Profiles in Healthy Subjects PDF |
$40.00 |
|
$40.00 |
|
× |
|
Comparison of Managed Care Charges Among Patients Treated With Selective Serotonin Reuptake Inhibitors for Premenstrual Dysphoric Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression PDF |
$40.00 |
|
$40.00 |
|
|
